BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Chapter

Reset

Presentation	Product	Chemical substance	Chapter	Items dispensed
Oxybutynin 5mg modified-release tablets 0704020J0AAASAS	Oxybutynin (Systemic)	Oxybutynin	Obstetrics, Gynaecology and Urinary-Tract Disorders	28,208
Pamsvax XL 400microgram capsules (Actavis) 0704010U0BIAAAA	Pamsvax	Tamsulosin hydrochloride	Obstetrics, Gynaecology and Urinary-Tract Disorders	27,999
Ovestin 1mg/g vaginal cream with applicator 0702010F0BCAAAA	Ovestin (Vaginal)	Estriol	Obstetrics, Gynaecology and Urinary-Tract Disorders	25,950
Fesoterodine 8mg modified-release tablets 0704020ADAAABAB	Fesoterodine fumarate	Fesoterodine fumarate	Obstetrics, Gynaecology and Urinary-Tract Disorders	25,719
Alfuzosin 2.5mg tablets 0704010A0AAAAAA	Alfuzosin hydrochloride	Alfuzosin hydrochloride	Obstetrics, Gynaecology and Urinary-Tract Disorders	24,156
Betmiga 50mg modified-release tablets 0704020AEBBABAB	Betmiga	Mirabegron	Obstetrics, Gynaecology and Urinary-Tract Disorders	21,859
Sayana Press 104mg/0.65ml inj pre-filled disposable devices 0703022M0BDAAAC	Sayana Press (Contraceptive)	Medroxyprogesterone acetate	Obstetrics, Gynaecology and Urinary-Tract Disorders	21,369
Noriday 350microgram tablets 0703021N0BCAAAA	Noriday	Norethisterone	Obstetrics, Gynaecology and Urinary-Tract Disorders	18,578
Darifenacin 7.5mg modified-release tablets 0704020ACAAAAAA	Darifenacin hydrobromide	Darifenacin hydrobromide	Obstetrics, Gynaecology and Urinary-Tract Disorders	16,677
Zelleta 75microgram tablets 0703021Q0BHAAAA	Zelleta	Desogestrel	Obstetrics, Gynaecology and Urinary-Tract Disorders	15,988
Millinette 20microgram/75microgram tablets 0703010E0BJAAAC	Millinette (20/75mcg)	Combined ethinylestradiol 20mcg	Obstetrics, Gynaecology and Urinary-Tract Disorders	14,523
Norethisterone 350microgram tablets 0703021N0AAAAAA	Norethisterone (Contraceptive)	Norethisterone	Obstetrics, Gynaecology and Urinary-Tract Disorders	14,320
Ethinylestradiol 30microgram / Drospirenone 3mg tablets 0703010F0AAAJAJ	Combined ethinylestradiol 30mcg	Combined ethinylestradiol 30mcg	Obstetrics, Gynaecology and Urinary-Tract Disorders	14,222
Darifenacin 15mg modified-release tablets 0704020ACAAABAB	Darifenacin hydrobromide	Darifenacin hydrobromide	Obstetrics, Gynaecology and Urinary-Tract Disorders	14,081
Vardenafil 20mg tablets 0704050AAAAACAC	Vardenafil	Vardenafil	Obstetrics, Gynaecology and Urinary-Tract Disorders	13,630
Metronidazole 0.75% vaginal gel 0702020X0AAAAAA	Metronidazole (Vaginal)	Metronidazole	Obstetrics, Gynaecology and Urinary-Tract Disorders	13,242
Clotrimazole 200mg pessaries 0702020F0AAAEAE	Clotrimazole (Vaginal)	Clotrimazole	Obstetrics, Gynaecology and Urinary-Tract Disorders	12,843
Millinette 30microgram/75microgram tablets 0703010F0BRAAAE	Millinette (30/75mcg)	Combined ethinylestradiol 30mcg	Obstetrics, Gynaecology and Urinary-Tract Disorders	12,302
Marvelon tablets 0703010F0BBAAAA	Marvelon	Combined ethinylestradiol 30mcg	Obstetrics, Gynaecology and Urinary-Tract Disorders	12,296
Fluconazole 150mg capsule and Clotrimazole 2% cream 0702020F0AAANAN	Clotrimazole (Vaginal)	Clotrimazole	Obstetrics, Gynaecology and Urinary-Tract Disorders	11,573
Lizinna 250microgram/35microgram tablets 0703010G0BGAAAC	Lizinna	Combined ethinylestradiol 35mcg	Obstetrics, Gynaecology and Urinary-Tract Disorders	11,070
Regurin XL 60mg capsules 0704020Z0BBABAD	Regurin	Trospium chloride	Obstetrics, Gynaecology and Urinary-Tract Disorders	10,960
Cilique 250microgram/35microgram tablets 0703010G0BHAAAC	Cilique	Combined ethinylestradiol 35mcg	Obstetrics, Gynaecology and Urinary-Tract Disorders	10,861
Microgynon 30 ED tablets 0703010F0BEABAH	Microgynon 30	Combined ethinylestradiol 30mcg	Obstetrics, Gynaecology and Urinary-Tract Disorders	10,044
Solifenacin 6mg / Tamsulosin 400microgram MR tab 0704010W0AAAAAA	Solifenacin/tamsulosin	Solifenacin/tamsulosin	Obstetrics, Gynaecology and Urinary-Tract Disorders	9,475

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.